Current understanding of Alzheimer’s disease diagnosis and treatment

Cited by (1,000)

Items 401–500 of 1,000

1. Analysis of Effect of Intensity of Aerobic Exercise on Cognitive and Motor Functions and Neurotrophic Factor Expression Patterns in an Alzheimer’s Disease Rat Model
   Do‐Youn Lee, Sang-Cheol Im, Na-Yeon Kang, Kyoung Kim · 2023 · Journal of Personalized Medicine
2. Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
   Devika Jadhav, Nikita Saraswat, Neeraj S. Vyawahare, Devendra Shriram Shirode · 2024 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
3. Causal association between plasma metabolites and neurodegenerative diseases
   Ao Zhang, Congcong Pan, Meifen Wu, Yue Lin, Jiashen Chen, Ni Zhong, Ruijie Zhang, Liyuan Pu, Liyuan Han, Haiyan Pan · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
4. Connexin43 Contributes to Alzheimer’s Disease by Promoting the Mitochondria-Associated Membrane-Related Autophagy Inhibition
   Weiwei Yu, Yunong Li, Yao Li, Jun Hu, Jun Wu, Xuhui Chen, Yining Huang, Xin Shi · 2024 · Molecular Neurobiology
5. Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer's disease
   Taha Basit Ameen, Umair Ali, Omme Salma, Muhammad Abdul Samee, Syed Muhammad Iraj Abbas, Syeda Naveera Kashif, Muhammad Arif Arifi, Mashooque Ali, Maher Khowaja, Syed Muhammad Sinaan Ali et al. · 2025 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
6. Sphingolipids and Inositol Phosphates Regulate the Tau Protein Phosphorylation Status in Humanized Yeast
   Francisca Rández‐Gil, Lino Bojunga, Francisco Estruch, Joris Winderickx, Maurizio Del Poeta, Jose Antonio Prieto · 2020 · Frontiers in Cell and Developmental Biology
7. Synthesis and Bioinformatic Characterization of New Schiff Bases with Possible Applicability in Brain Disorders
   Speranța Avram, Ana-Maria Udrea, Diana Camelia Nuță, Carmen Limban, Adrian Cosmin Balea, Miron Teodor Căproiu, Florea Dumitraşcu, Cătălin Buiu, ALEXANDRA TEODORA BORDEI TELEHOIU · 2021 · Molecules
8. Engineering extracellular vesicles for Alzheimer's disease: An emerging cell‐free approach for earlier diagnosis and treatment
   Sabrina Valentina Lazar, Sirjan Mor, David Wang, Leora Goldbloom‐Helzner, Kaitlin C. Clark, Dake Hao, Diana Lee Farmer, Aijun Wang · 2021 · WIREs Mechanisms of Disease
9. Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
   Gaofeng Qin, Yunfang Dong, Zhenhong Liu, Zhuoyan Gong, Chenyan Gao, Mingcui Zheng, Meijing Tian, Yannan He, Liqun Zhong, Pengwen Wang · 2021 · Chinese Medicine
10. Optimizations for Computing Relatedness in Biomedical Heterogeneous Information Networks: SemNet 2.0
    Anna Kirkpatrick, Chidozie Onyeze, David Kartchner, Stephen A. Allegri, Davi Nakajima An, Kevin McCoy, Evie Davalbhakta, Cassie S. Mitchell · 2022 · Big Data and Cognitive Computing
11. I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice
    Bibiana Castagna Mota, Nathan Ashburner, Laura Esther Abelleira, Liyueyue Liu, Robertas Aleksynas, Lucio Claudio Rovati, Gianfranco Caselli, Magdalena Sastre · 2022 · International Journal of Molecular Sciences
12. Exploiting task relationships for Alzheimer’s disease cognitive score prediction via multi-task learning
    Wei Liang, Kai Zhang, Peng Cao, Xiaoli Liu, Jinzhu Yang, Osmar R. Zai͏̈ane · 2022 · Computers in Biology and Medicine
13. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition
    Yi Jayne Tan, Isabel Siow, Seyed Ehsan Saffari, Simon K. S. Ting, Li Zeng, Nagaendran Kandiah, Louis C.S. Tan, Eng‐King Tan, Adeline Su Lyn Ng · 2023 · Journal of Alzheimer s Disease
14. Hepatic and cardiac implications of increased toxic amyloid-beta serum level in lipopolysaccharide-induced neuroinflammation in rats: new insights into alleviating therapeutic interventions
    Mai M. Anwar, Abeer A. Mabrouk · 2023 · Inflammopharmacology
15. Studying ancient human oral microbiomes could yield insights into the evolutionary history of noncommunicable diseases
    Abigail Shahar Gancz, Laura Susan Weyrich · 2023 · F1000Research
16. CD33 rs3865444 as a risk factor for Parkinson’s disease
    Vasileios Siokas, Stylianos Arseniou, Athina‐Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Markos N. Sgantzos, Panagiotis Liakos, Dimitrios Petrou Bogdanos, Georgios M. Hadjigeorgiou, Efthimios Dardiotis · 2021 · Neuroscience Letters
17. Altered metabolic pathways in a transgenic mouse model suggest mechanistic role of amyloid precursor protein overexpression in Alzheimer’s disease
    Hattapark Dejakaisaya, Anna Harutyunyan, Patrick Kwan, Nigel C. Jones · 2021 · Metabolomics
18. Phytochemical analysis and versatile in vitro evaluation of antimicrobial, cytotoxic and enzyme inhibition potential of different extracts of traditionally used Aquilegia pubiflora Wall. Ex Royle
    Hasnain Jan, Hazrat Usman, Muzamil Shah, Gouhar Zaman, Sadaf Mushtaq, Samantha Drouet, Christophe Hano, Bilal Haider Abbasi · 2021 · BMC Complementary Medicine and Therapies
19. Alzheimer’s disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities
    Krzysztof Bednarz, Joanna S. Siuda · 2021 · Neurologia i Neurochirurgia Polska
20. Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
    Αndroulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia · 2025 · Biomolecules
21. Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
    Sarmistha Mitra, Yeasmin Akter Munni, Raju Dash, Toma Sadhu, Largess Barua, Md. Ariful Islam, Dipannita Chowdhury, Debpriya Bhattacharjee, Kishor Mazumder, Il Soo Moon · 2023 · Life
22. Cyanidin improves spatial memory and cognition in bisphenol A-induced rat model of Alzheimer's-like neuropathology by restoring canonical Wnt signaling
    Swathi Suresh, Chitra Vellapandian · 2024 · Toxicology and Applied Pharmacology
23. The protective effect of Astaxanthin on scopolamine - induced Alzheimer’s model in mice
    Rania M. Magadmi, Sara Nassibi, Fatemah O. Kamel, Aziza Alrafiah, Duaa Bakhshwin, Maha Jamal, Mohammed Alsieni, Abdulhadi S. Burzangi, Mohammed Zaher, Mohammed Bendary · 2024 · Neurosciences
24. Identification of cuproptosis-related genes in Alzheimer’s disease based on bioinformatic analysis
    Mingming Ma, Jing Zhao, Ling Liu, Cai-ying Wu · 2024 · European journal of medical research
25. Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease
    Mona Abdelhamid, Scott Counts, Chunyu Zhou, Hideki Hida, Jae‐Il Kim, Makoto Michikawa, Cha‐Gyun Jung · 2025 · Nutrients
26. The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects
    Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy · 2025 · Toxicology Reports
27. Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice
    Tim Ebert, Daniel E. Heinz, Suellen Almeida-Corrêa, Renata Cruz, Frederik Dethloff, Tibor Štark, Thomas Bajaj, Oriana Maria Maurel, Fabiola Mara Ribeiro, Silvio Calcagnini et al. · 2021 · Frontiers in Aging Neuroscience
28. Modern Perspectives of Curcumin and its Derivatives as Promising Bioactive and Pharmaceutical Agents
    2021 · Biointerface Research in Applied Chemistry
29. Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation
    Justin P. Wright, Jason R. Goodman, Yin‐Guo Lin, Brian P. Lieberman, Jennifer Clemens, Luis F. Gomez, Qianwa Liang, Adam T. Hoye, Michael J. Pontecorvo, Kelly A. Conway · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
30. Lipid Mass Tags via Aziridination for Probing Unsaturated Lipid Isomers and Accurate Relative Quantification**
    Tingyuan Yang, Shuli Tang, Syuan-Ting Alex Kuo, Dallas P. Freitas, Madison E. Edwards, Hongying Wang, Yuxiang Sun, Xin Yan · 2022 · Angewandte Chemie
31. Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease
    Nathan Herrmann, Hui Jue Wang, Bing Xin Song, Kritleen Kaur Bawa, Krista L. Lanctôt · 2022 · Expert Opinion on Drug Safety
32. The Allosteric Antagonist of the Sigma-2 Receptors—Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer’s Disease: A Scoping Systematic Review
    Anum Rasheed, Ahmad Bin Zaheer, Aqsa Munawwar, Zouina Sarfraz, Azza Sarfraz, Karla Robles‐Velasco, Iván Chérrez-Ojeda · 2022 · Life
33. c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations
    Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, Miren Ettcheto, Antoni Camins, Carlos Beas‐Zárate, Ruben Dario Castro-Torres, Carme Auladell · 2020 · Journal of Alzheimer s Disease
34. A Practical and High‐Affinity Fluorescent Probe for Butyrylcholinesterase: A Good Strategy for Binding Affinity Characterization
    Lei Wang, Chenxi Du, Hui Liu, Weimin Qiu, Xin Lü, Yanyu Hu, Yueqing Li, Tian‐Yu Sun, Yao Chen, Haopeng Sun · 2022 · Chinese Journal of Chemistry
35. The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties
    Chenqi Lu, Cong Xu, Jun Yang · 2024 · Medicina
36. Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer’s Disease
    Baoshan Li, Min Zhou, Jing Yun Peng, Qiao Yang, Jingxin Chu, Ruoqing Li, Yi Jiang · 2021 · Immunological Investigations
37. Image processing: an early detection tool for Alzheimer’s disease
    Sangeeta Ballav, Bini Biswas, Saurabh Dey, Vishal Kumar Sahu, Soumya Basu · 2023 · Elsevier eBooks
38. The comprehensive mechanism underlying Schisandra polysaccharide in AD-like symptoms of Aβ25-35-induced rats based on hippocampal metabolomics and serum lipidomics techniques
    Shuo Zhao, Jinpeng Zhang, Yufeng Chen, Xinyuan Cui, Haiqing Liu, Ying Yan, Yuexiang Sun, QI Yong-xiu, Yuanyuan Liu · 2023 · Journal of Pharmaceutical and Biomedical Analysis
39. Oligosaccharides from black ginseng innovatively prepared by low‐temperature steam‐heating process ameliorate cognitive impairment in Alzheimer's disease mice via the Keap‐1/Nrf2 pathway
    Weiyin Xu, Peng Yu, Simeng Shao, Zhaoyang Xie, Yi Wu, Jianing Liu, Tianyang Xu, Guangzhi Cai, Hongmei Yang · 2024 · Journal of the Science of Food and Agriculture
40. Diosmin ameliorates inflammation, apoptosis and activates PI3K/AKT pathway in Alzheimer’s disease rats
    Yanbo Wang, Xiaojun Ye, Wenwen Su, Ci Yan, Haiyan Pan, Xiaowei Wang, Sen Shao · 2024 · Metabolic Brain Disease
41. Global Mapping of Interventions to Improve Quality of Life of Patients with Alzheimer’s Disease during 1990–2018
    Chi Linh Hoang, Giang Hai Ha, Kiet Tuan Huy Pham, Bach Xuan Tran, Carl Asher Latkin, Cyrus S. H. Ho, Roger Ho · 2019 · Dementia and Geriatric Cognitive Disorders
42. A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers
    Marjan Talebi, Hadi Esmaeeli, Mohsen Talebi, Tahereh Farkhondeh, Saeed Samarghandian · 2021 · Current Pharmaceutical Biotechnology
43. Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease
    Mohamed Raâfet Ben Khedher, Mohamed Haddad, Danielle Laurin, Charles Ramassamy · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
44. GH deficiency confers protective advantages against Alzheimer’s disease through rescued miRNA expression profile in APP/PS1 mice
    Sarah A. Noureddine, Tatiana D. Saccon, Trina Rudeski-Rohr, Adam Gesing, Jeffrey B. Mason, Augusto Schneider, Joseph Dhabhi, Kendra L. Puig, Sharlene G. Rakoczy, Holly M. Brown‐Borg et al. · 2022 · GeroScience
45. MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis
    Shengyu Li, Lishuo Wu, Meigang Ma, Long-Xiu Yang, Chao Qin · 2022 · Annals of Translational Medicine
46. Synthesis, Characterization and Biological Evaluation of Benzothiazole–Isoquinoline Derivative
    Weihua Liu, Donghai Zhao, Zhi‐Wen He, Yi-Ming Hu, Yu-Xia Zhu, Lingjian Zhang, Lianhai Jin, Liping Guan, Sihong Wang · 2022 · Molecules
47. PR-957 Suppresses Th1 and Th17 Cell Differentiation via Inactivating PI3K/AKT Pathway in Alzheimer’s Disease
    Yuanlong Li, Hua Fan, Xiong Han, Jun Sun, Ming Ni, Lulu Zhang, Fengqin Fang, Wei Zhang, Peizhi Ma · 2022 · Neuroscience
48. Mesenchymal Stem Cells for Treating Alzheimer’s Disease: Cell Therapy and Chemical Reagent Pretreatment
    Kexin Zhang, Xinzhe Du, Yao Gao, Sha Liu, Yong Xu · 2023 · Journal of Alzheimer s Disease
49. DEAD-Box Helicase 17 Promotes Amyloidogenesis by Regulating BACE1 Translation
    Yue Liu, Gui‐Feng Zhou, Song Li, Qi‐Xin Wen, Shiqi Xie, Long Chen, Lu Wang, Xiao‐Yong Xie, Xue Chen, Yalan Pu et al. · 2023 · Brain Sciences
50. In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology
    Ankul Singh S, Chitra Vellapandian · 2023 · Future Science OA
51. Blood and Cerebrospinal Fluid Autoantibody to Aβ Levels in Patients with Alzheimer’s Disease: a Meta-Analysis Study
    Xiaowan Li, Xixi Li, Qingshan Liu, Yong Cheng · 2020 · Journal of Molecular Neuroscience
52. A Multi-Modal Deep Learning Approach to the Early Prediction of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
    Sijan S Rana, Xinhui Ma, Wei Pang, Emma Wolverson · 2020 · IEEE/ACM International Conference on Big Data Computing, Applications and Technologies (BDCAT)
53. Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
    Žofia Chrienová, Eugenie Nepovimová, Rudolf Andrýs, Rafael Doležal, Jana Janočková, Ľubica Múčková, Lenka Fabova, Ondřej Soukup, Patrik Olekšák, Martin Vališ et al. · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
54. Synthesis of aurone sulfonate derivatives: Evaluation of their cholinesterase inhibition, neuroprotective effects, and expression of oxidative stress-related genes
    Abdolrahim Pourparizi, Hamid Nadri, Navid Naghsh, Ahmad Reza Eider, Fatemeh Pourrajab · 2023 · Journal of Molecular Structure
55. Understanding Alzheimer’s Disease and its Metal Chelation Therapeutics: A Narrative Review
    Ritik Thakur, Ritu Karwasra, Tarana Umar · 2023 · Current Pharmaceutical Design
56. The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases
    Manthia A. Papageorgakopoulou, Angelina Bania, Ioanna-Aglaia Lagogianni, Kyriakos Birmpas, Martha Assimakopoulou · 2024 · Molecular Neurobiology
57. Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer’s Disease and Phytochemicals-Based Interventions
    Harkomal Verma, Sharanjot Kaur, Sukhchain Kaur, Prabhakar Gangwar, Monisha Dhiman, Anil Kumar Mantha · 2024 · Molecular Neurobiology
58. Direct Clinical Applications of Natural Language Processing in Common Neurological Disorders: Scoping Review
    Ilana Lefkovitz, Samantha Walsh, Leah J. Blank, Nathalie Jetté, Benjamin R. Kummer · 2024 · JMIR Neurotechnology
59. Inducing Agents for Alzheimer’s Disease in Animal Models
    Karishma Khan, Nasr Ali Emad, Yasmin Sultana · 2024 · Journal of Exploratory Research in Pharmacology
60. Exploring Novel Quinoline-1,3,4-Oxadiazole Derivatives for Alzheimer’s Disease: Their Design, Synthesis, and In-Vitro and In-Silico Investigations
    Sana Saffour, Asaf Evrim Evren, Begüm Nurpelin Sağlık, Leyla Yurttaş · 2024 · Current Medicinal Chemistry
61. The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases
    Şeyma Aydın, Selçuk Özdemir, Ahmet Adıgüzel · 2025 · Journal of Molecular Neuroscience
62. Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
    Youssef M. Mousa, Ihab M. Abdallah, Misako Hwang, Douglas R. Martin, Amal Kaddoumi · 2020 · Scientific Reports
63. The molecular mechanisms of signal pathway activating effect of E2F-1/NF-κB/GSK-3β on cognitive dysfunction of Alzheimer rats
    Mayila Tuerxun, Ajar Muhda, Lixin Yin · 2021 · Bioengineered
64. Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model
    Avneet Kour, Taru Dube, Ashwani Kumar, Jiban Jyoti Panda · 2022 · Bioconjugate Chemistry
65. Alzheimer Caregiving Problems According to ADLs: Evidence from Facebook Support Groups
    Pavel Bachmann, Jan Hruška · 2022 · International Journal of Environmental Research and Public Health
66. N‐Substituted Arylidene‐3‐(Methylsulfonyl)‐2‐Oxoimidazolidine‐1‐Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study
    Fatih Tok, Begüm Nurpelin Sağlık, Yusuf Özkay, Zafer Asım Kaplancıklı, Bedia Koçyiğit‐Kaymakçıoğlu · 2022 · Chemistry & Biodiversity
67. Identification of small molecules against the NMDAR: an insight from virtual screening, density functional theory, free energy landscape and molecular dynamics simulation-based findings
    Garima Sharma, Rohit Shukla, Tiratha Raj Singh · 2022 · Network Modeling Analysis in Health Informatics and Bioinformatics
68. Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
    Glen R. Wunderlich, Zuzana Blahova, Miguel García, Frank Jessen · 2023 · Alzheimer s Research & Therapy
69. Genetic Factors Implicated in the Investigation of Possible Connections between Alzheimer’s Disease and Primary Open Angle Glaucoma
    Grace Kuang, Rebecca Salowe, Joan M. O’Brien · 2023 · Genes
70. Molecular and Structural Insight into Adenosine A2A Receptor in Neurodegenerative Disorders: A Significant Target for Efficient Treatment Approach
    Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy · 2023 · Molecular Neurobiology
71. Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic single-cell analysis
    Jay Sibbitts, Christopher T. Culbertson · 2020 · Analytical Methods
72. Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review
    Manuel Glauco Carbone, Giovanni Pagni, Claudia Tagliarini, Donatella Marazziti, Nunzio Pomara · 2021 · Life
73. The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis
    Wenting Zhang, G.X. Zhang, Shuaishuai Gao · 2021 · Neurología
74. Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration
    Yusuke Hatakawa, Akiko Tanaka, Tomoyuki Furubayashi, Rina Nakamura, Motomi Konishi, Toshifumi Akizawa, Toshiyasu Sakane · 2021 · Pharmaceutics
75. Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease Complicated With Osteoporosis
    Weifan Xu, Yiping Jiang, Nani Wang, Huanhuan Bai, Shengyan Xu, Tianshuang Xia, Hailiang Xin · 2022 · Frontiers in Pharmacology
76. Trends and forecasts of the prevalence and mortality of Alzheimer’s disease and other dementias in China
    Mingxuan Hou, Ling Yang · 2025 · Frontiers in Public Health
77. Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.
    Feng Niu, Aruna Sharma, Zhenguo Wang, Lian-Yuan Feng, D. Muresanu, S. Sahib, Z. Tian, J. Lafuente, A. Buzoianu, R. Castellani et al. · 2021 · Progress in Brain Research
78. MRI Segmentation of Brain Tissue and Course Classification in Alzheimer’s Disease
    Meimei Li, Chunhai Hu, Zhen Liu, Ying Zhou · 2022 · Electronics
79. NEK7 inhibition attenuates Aβ42-induced cognitive impairment by regulating TLR4/NF-κB and the NLRP3 inflammasome in mice
    Peng Li, Yifan He, Qian Yang, Hena Guo, Nini Li, Dongdong Zhang · 2023 · Journal of Clinical Biochemistry and Nutrition
80. Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer’s Disease
    Hammad Qaiser, Mohammad Uzair, Khalid Al-Regaiey, Shafia Rafiq, Muhammad Arshad, Woo‐Kyoung Yoo, Osama Zahid Arain, Imdad Kaleem, Turki Abualait, Lan Wang et al. · 2023 · Journal of Alzheimer s Disease
81. SHMT2 Mediates Small‐Molecule‐Induced Alleviation of Alzheimer Pathology Via the 5′UTR‐dependent ADAM10 Translation Initiation
    Li Song, Qiuling Pan, Gui‐Feng Zhou, Shengwei Liu, Binglin Zhu, Peijia Lin, Xiaotong Hu, Jing‐Si Zha, Yan Long, Biao Luo et al. · 2024 · Advanced Science
82. Genetic markers associated with ferroptosis in Alzheimer’s disease
    Yuting Sun, Yu Xiao, Qin Tang, Wei Chen, Lin Lü · 2024 · Frontiers in Aging Neuroscience
83. Insights into AlphaFold’s breakthrough in neurodegenerative diseases
    Hira Mubeen, Ammara Masood, Asma Zafar, Zohaira Qayyum Khan, Muneeza Qayyum Khan, Alim un Nisa · 2024 · Irish Journal of Medical Science (1971 -)
84. Efficacy and safety of acupuncture for cognitive impairment in Alzheimer's disease: a systematic review and meta-analysis
    Ruyue Guo, Xiaoming Shen, John Ealing, Jiao Zhou, Jin Lu, Yunfan Ning · 2024 · Frontiers in Dementia
85. Probing locus coeruleus functional network in healthy aging and its association with Alzheimer’s disease biomarkers using pupillometry
    Junjie Wu, Aaron Toporek, Qixiang Lin, Felicia C. Goldstein, David W. Loring, Michael A. Kelberman, David Weinshenker, Allan I. Levey, James J. Lah, Deqiang Qiu · 2025 · Alzheimer s Research & Therapy
86. Aplysia Neurons as a Model of Alzheimer’s Disease: Shared Genes and Differential Expression
    Nicholas S. Kron, Lynne A. Fieber · 2021 · Journal of Molecular Neuroscience
87. The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease
    Maria Podsiedlik, Magdalena Markowicz-Piasecka, Joanna Sikora · 2022 · International Journal of Molecular Sciences
88. Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study
    Valérie Bourdès, Peter Dogterom, André Aleman, Pierre Parmantier, Damien Colas, Sighild Lemarchant, Sébastien Marie, Thomas Chou, Khalid Abd‐Elaziz, Yann Godfrin · 2022 · Neurology and Therapy
89. The Parietal Lobe in Alzheimer’s Disease and Blindness
    Mónica-Alba Ahulló-Fuster, Tomás Ortiz, Enrique Varela-Donoso, Juan Nácher, M. Luz Sánchez-Sánchez · 2022 · Journal of Alzheimer s Disease
90. Genetic dependency of Alzheimer’s disease-associated genes across cells and tissue types
    Suraj K. Jaladanki, Abdülkadir Elmas, Gabriel Santos Malavé, Kuan‐lin Huang · 2021 · Scientific Reports
91. Germacrone alleviates okadaic acid-induced neurotoxicity in PC12 cells via M1 muscarinic receptor-mediated Galphaq (Gq)/phospholipase C beta (PLCβ)/ protein kinase C (PKC) signaling
    Mingqin Lin, Peiqiong Li, Wei Liu, Tianqi Niu, Liping Huang · 2022 · Bioengineered
92. A Review on Importance of Artificial Intelligence in Alzheimer’s Disease and it’s Future Outcomes for Alzheimer’s Disease
    Patel Minesh · 2022 · Research Journal of Pharmacology and Pharmacodynamics
93. Computer Internet of Things‐Based Intelligent Medical System to Be Applied in Home Care of Senile Dementia Patients
    Qiong Wang · 2022 · Wireless Communications and Mobile Computing
94. Classification of Alzheimer’s Disease Based on Weakly Supervised Learning and Attention Mechanism
    Xiaosheng Wu, Shuangshuang Gao, Junding Sun, Yudong Zhang, Shuihua Wang‎ · 2022 · Brain Sciences
95. The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach
    Thais Guimarães Martins Nery, E. Silva, Raphael Tavares, F. Passetti · 2018 · Journal of Molecular Neuroscience
96. Estimating prevalence of early symptomatic Alzheimer's disease in the United States
    Spargo, Drew, Zur, Richard, Lin, Pei‐Jung, Synnott, Patricia, Klein, Eric, Hartry, Ann · 2023 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
97. ASSOCIATION BETWEEN ALZHEIMER’S DISEASE AND APOE GENE GENOTYPIC POLYMORPHISMS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Mateus Gonçalves Pereira, Lucas Cândido Gonçalves, Paulo Alex Neves da Silva, Lí­lian Carla Carneiro, Xisto Sena Passos, Milton Camplesi, Fábio Silvestre Ataídes, Antônio Márcio Teodoro Cordeiro Silva, Fábio Marques de Almeida · 2022 · Editora Conhecimento Livre eBooks
98. The involvement of effector memory CD4+ T cells in mediating the impact of genus Oscillibacter gut microbiota on Alzheimer’s disease: a Mendelian randomization study
    Huachang Zhang, Yudong Wang, Hui Zhao, Wei Wang, Fabin Han · 2024 · Frontiers in Aging Neuroscience
99. Recent Insights on the Role of Nuclear Receptors in Alzheimer’s Disease: Mechanisms and Therapeutic Application
    Xiaoxiao Shan, Dawei Li, Huihui Yin, Wenwen Tao, Lele Zhou, Yu Wei Gao, Chengjie Xing, Caiyun Zhang · 2025 · International Journal of Molecular Sciences
100. Oxidative stress, inflammation, and apoptosis in Alzheimer’s disease associated with HSV-1 and CMV coinfection
     Sepideh Khodamoradi, Forouzan Khodaei, Taher Mohammadian, Atousa Ferdousi, Fatemeh Rafiee · 2025 · Virology Journal